SCLX
SCLX
NASDAQ · Pharmaceuticals

Scilex Holding Co

$7.52
-0.28 (-3.59%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +412.4% upside
Low Target $25.32
Average Target $38.53
High Target $55.24
Current Price $7.52
Current
$7.52
Target
$38.53
$25.32 $38.53 avg $55.24
Scenario Analysis
Bear Case
$25.32
236.7%
Low target
Base Case
$38.53
+412.4%
Avg target
Bull Case
$55.24
+634.6%
High target
Risk/Reward
2.7x
Favorable
Price in Context
52-Week High
$34.27
-78.1% from high
52-Week Low
$3.60
+108.9% from low
Target vs 52W High
$38.53
+12.4% vs high
Next Earnings Report
Mar 30, 2026 · Before Market Open
3d
until earnings
EPS Est: $-0.48
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
Buy 18 67% $122.82 +809.8%